{"id":4658,"date":"2018-11-30T11:30:00","date_gmt":"2018-11-30T11:30:00","guid":{"rendered":"https:\/\/www.waters.com\/blog\/future-proofing-pharmaceutical-rd-to-accelerate-aerosol-science-innovation\/"},"modified":"2023-07-06T15:31:48","modified_gmt":"2023-07-06T15:31:48","slug":"future-proofing-pharmaceutical-rd-to-accelerate-aerosol-science-innovation","status":"publish","type":"post","link":"https:\/\/www.waters.com\/blog\/future-proofing-pharmaceutical-rd-to-accelerate-aerosol-science-innovation\/","title":{"rendered":"Future-Proofing Pharmaceutical R&D to Accelerate Aerosol Science Innovation"},"content":{"rendered":"

At Chiesi Group\u2019s Chippenham laboratory in the UK, Waters\u2019 UPLC systems with mass detection and informatics keep the team at the forefront of inhalation drug delivery products<\/h2>\n

Waters UPLC systems with the ACQUITY QDa Mass Detector and informatics solutions enable pharmaceutical R&D teams to stay at the cutting edge of aerosol and inhalation drug delivery research at the Chiesi Group\u2019s Chippenham laboratory<\/a> in the UK.<\/p>\n

 <\/p>\n

\"\"<\/a><\/p>\n

 <\/p>\n

It\u2019s becoming more important for pharmaceutical companies like the Chiesi Group to integrate forward-looking strategies to achieve excellence and use their growing knowledge to make decisions quickly. Dr\u00a0David Lewis, Director of Aerosol Research at The Chiesi Group and co-inventor of 29 patents relating to pressurized metered dose inhaler formulations and devices, states that for a product to be launched in 5-10 years, they need to be 20-30 years ahead in their research.<\/p>\n

Chiesi Group believes that collaboration is key to success, this focus on entrepreneurial collaboration serves as the basis of the 10-year relationship between its researchers and Waters. Dr. Lewis believes that the partnership between Waters and the Chiesi Gropu serves as the basis for the company’s growing success.<\/p>\n

\u201cThe pharmaceutical industry needs to stay ahead of the game if they\u2019re going to deliver tomorrow\u2019s medicines,\u201d says Dr. David Lewis at Chiesi Group.<\/em><\/p><\/blockquote>\n

Dr Lewis explains, \u201cYou always need new instrumentation new concepts, new ideas. We\u2019re here to research and problem solve as much as we can. If you do not keep ahead of this thinking, someone else will.\u201d<\/p>\n

Quality instrumentation and software from Waters has allowed Chiesi scientists to maximize the applicability of their research and the innovations that result from it.<\/p>\n

Read more<\/a> about how the relationship between Chiesi and Waters has enabled Dr. Lewis and his team to continue to push the boundaries of the drug discovery research process.<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

At Chiesi Group\u2019s Chippenham laboratory in the UK, Waters\u2019 UPLC systems with mass detection and informatics keep the team at the forefront of inhalation drug delivery products.<\/p>\n","protected":false},"author":96,"featured_media":5058,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"","_seopress_titles_title":"Accelerating Aerosol Science Innovation in Pharma R&D | Waters Blog","_seopress_titles_desc":"Waters' UPLC systems with mass detection and informatics solutions empower Chiesi Group's Chippenham laboratory to lead inhalation drug delivery research.\r\n","_seopress_robots_index":"","_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[25],"tags":[126,96,40],"class_list":["post-4658","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceutical","tag-acquity-qda","tag-case-study","tag-pharmaceuticals"],"acf":[],"taxonomy_info":{"category":[{"value":25,"label":"Pharmaceutical"}],"post_tag":[{"value":126,"label":"ACQUITY QDa"},{"value":96,"label":"case study"},{"value":40,"label":"pharmaceuticals"}]},"featured_image_src_large":["https:\/\/www.waters.com\/blog\/wp-content\/uploads\/6294-chiesi-625x400-2.jpg",625,400,false],"author_info":{"display_name":"Barry Upton","author_link":"https:\/\/www.waters.com\/blog\/author\/bupton\/"},"comment_info":"","category_info":[{"term_id":25,"name":"Pharmaceutical","slug":"pharmaceutical","term_group":0,"term_taxonomy_id":25,"taxonomy":"category","description":"We bring high-value technologies designed to solve critical, analytical problems. We enable profound discoveries, optimize lab operations and ensure regulatory compliance. We help customers turn global industry challenges into the medicines that offer hope.","parent":0,"count":91,"filter":"raw","term_order":"0","cat_ID":25,"category_count":91,"category_description":"We bring high-value technologies designed to solve critical, analytical problems. We enable profound discoveries, optimize lab operations and ensure regulatory compliance. We help customers turn global industry challenges into the medicines that offer hope.","cat_name":"Pharmaceutical","category_nicename":"pharmaceutical","category_parent":0}],"tag_info":[{"term_id":126,"name":"ACQUITY QDa","slug":"acquity-qda","term_group":0,"term_taxonomy_id":126,"taxonomy":"post_tag","description":"","parent":0,"count":17,"filter":"raw","term_order":"0"},{"term_id":96,"name":"case study","slug":"case-study","term_group":0,"term_taxonomy_id":96,"taxonomy":"post_tag","description":"","parent":0,"count":18,"filter":"raw","term_order":"0"},{"term_id":40,"name":"pharmaceuticals","slug":"pharmaceuticals","term_group":0,"term_taxonomy_id":40,"taxonomy":"post_tag","description":"","parent":0,"count":5,"filter":"raw","term_order":"0"}],"_links":{"self":[{"href":"https:\/\/www.waters.com\/blog\/wp-json\/wp\/v2\/posts\/4658","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.waters.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.waters.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.waters.com\/blog\/wp-json\/wp\/v2\/users\/96"}],"replies":[{"embeddable":true,"href":"https:\/\/www.waters.com\/blog\/wp-json\/wp\/v2\/comments?post=4658"}],"version-history":[{"count":0,"href":"https:\/\/www.waters.com\/blog\/wp-json\/wp\/v2\/posts\/4658\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.waters.com\/blog\/wp-json\/wp\/v2\/media\/5058"}],"wp:attachment":[{"href":"https:\/\/www.waters.com\/blog\/wp-json\/wp\/v2\/media?parent=4658"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.waters.com\/blog\/wp-json\/wp\/v2\/categories?post=4658"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.waters.com\/blog\/wp-json\/wp\/v2\/tags?post=4658"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}